Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
1,715.00
+60.00
+(3.63%)
At close: February 21 at 3:29:31 PM GMT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 5 | 5 |
| Avg. Estimate | 97.99M | 103.68M | 454.43M | 629.05M |
| Low Estimate | 87.5M | 103.68M | 426.1M | 520.91M |
| High Estimate | 108.48M | 103.68M | 488.37M | 697.47M |
| Year Ago Sales | -- | -- | 93.38M | 454.43M |
| Sales Growth (year/est) | -- | -- | 386.64% | 38.42% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ALVO.IC | -- | -- | -- | -- |
| S&P 500 | 14.59% | 7.50% | 10.82% | 14.15% |
Upgrades & Downgrades
| Initiated | UBS: Buy | 2/14/2025 |
| Maintains | Barclays: Overweight to Overweight | 7/25/2024 |
| Maintains | Barclays: Overweight to Overweight | 5/24/2024 |
| Maintains | Barclays: Overweight to Overweight | 3/22/2024 |
| Upgrade | Barclays: Equal-Weight to Overweight | 1/29/2024 |
| Upgrade | Citigroup: Sell to Neutral | 10/20/2023 |
Related Tickers
EVT.VI Evotec SE
8.50
-0.82%
TKUN.TA Tikun Olam-Cannbit Pharmaceuticals Ltd
38.00
-5.00%
PLCN.CN Cannibble Food-Tech Ltd.
0.0200
-33.33%
N4P.L N4 Pharma Plc
0.5750
0.00%
BOI.PA Boiron SA
25.20
+1.00%
TEV.F Teva Pharmaceutical Industries Limited
16.10
-2.13%
RJF.MC Laboratorio Reig Jofre, S.A.
2.6900
+1.13%
3320.HK China Resources Pharmaceutical Group Limited
5.480
+1.29%
DICOT.ST Dicot Pharma AB
0.2655
+1.53%
BIOG-B.ST BioGaia AB (publ)
127.00
-0.31%